Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 42, 2012 - Issue 10
465
Views
24
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers

, , , , , , , , , & show all
Pages 968-979 | Received 23 Jan 2012, Accepted 13 Mar 2012, Published online: 19 Apr 2012

References

  • Abadie-Viollon C, Martin H, Blanchard N, Pekthong D, Bachellier P, Mantion G, Heyd B, Schuler F, Coassolo P, Alexandre E, Richert L. (2010). Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions. Toxicol In Vitro 24:346–356.
  • Alexandre E, Viollon-Abadie C, David P, Gandillet A, Coassolo P, Heyd B, Mantion G, Wolf P, Bachellier P, Jaeck D, Richert L. (2002). Cryopreservation of adult human hepatocytes obtained from resected liver biopsies. Cryobiology 44:103–113.
  • Aueviriyavit S, Furihata T, Morimoto K, Kobayashi K, Chiba K. (2007). Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers. Drug Metab Pharmacokinet 22:391–398.
  • Badolo L, Trancart MM, Gustavsson L, Chesné C. (2011). Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytes. Chem Biol Interact 190:165–170.
  • Bi YA, Kazolias D, Duignan DB. (2006). Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport. Drug Metab Dispos 34:1658–1665.
  • Bissell DM, Stamatoglou SC, Nermut MV, Hughes RC. (1986). Interactions of rat hepatocytes with type IV collagen, fibronectin and laminin matrices. Distinct matrix-controlled modes of attachment and spreading. Eur J Cell Biol 40:72–78.
  • Blanchard N, Alexandre E, Abadie C, Lavé T, Heyd B, Mantion G, Jaeck D, Richert L, Coassolo P. (2005). Comparison of clearance predictions using primary cultures and suspensions of human hepatocytes. Xenobiotica 35:1–15.
  • Blanchard N, Hewitt NJ, Silber P, Jones H, Coassolo P, Lavé T. (2006). Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations. J Pharm Pharmacol 58:633–641.
  • Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. (1985). Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34:3337–3345.
  • De Bruyn T, Ye ZW, Peeters A, Sahi J, Baes M, Augustijns PF, Annaert PP. (2011). Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes. Eur J Pharm Sci 43:297–307.
  • Donato MT, Castell JV, Gómez-Lechón MJ. (1999). Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. J Hepatol 31:542–549.
  • Donato MT, Gómez-Lechón MJ, Castell JV. (1993). A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. Anal Biochem 213:29–33.
  • Dou M, de Sousa G, Lacarelle B, Placidi M, Lechene de la Porte P, Domingo M, Lafont H, Rahmani R. (1992). Thawed human hepatocytes in primary culture. Cryobiology 29:454–469.
  • Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM, Lindley CM. (2000). Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metab Dispos 28:1222–1230.
  • FDA. 2006). Guidance for Industry. Drug Interaction Studies - Study Design, Data Analysis, and Implications for Dosing and Labeling (Draft Guidance), U.S. Department of Health and Human Services, Food and Drug Administrationm
  • Foster JA, Houston JB, Hallifax D. (2011). Comparison of intrinsic clearances in human liver microsomes and suspended hepatocytes from the same donor livers: clearance-dependent relationship and implications for prediction of in vivo clearance. Xenobiotica 41:124–136.
  • Gómez-Lechón MJ, Castell JV, Donato MT. (2007). Hepatocytes–the choice to investigate drug metabolism and toxicity in man: in vitrovariability as a reflection of in vivo. Chem Biol Interact 168:30–50.
  • Gómez-Lechón MJ, Castell JV, Donato MT. (2008). An update on metabolism studies using human hepatocytes in primary culture. Expert Opin Drug Metab Toxicol 4:837–854.
  • Gómez-Lechón MJ, Castell JV, Donato MT. (2010). The use of hepatocytes to investigate drug toxicity. Methods Mol Biol 640:389–415.
  • Hamilton GA, Jolley SL, Gilbert D, Coon DJ, Barros S, LeCluyse EL. (2001). Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions. Cell Tissue Res 306:85–99.
  • Hengstler JG, Utesch D, Steinberg P, Platt KL, Diener B, Ringel M, Swales N, Fischer T, Biefang K, Gerl M, Böttger T, Oesch F. (2000). Cryopreserved primary hepatocytes as a constantly available in vitromodel for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab Rev 32:81–118.
  • Hewitt NJ, Bühring KU, Dasenbrock J, Haunschild J, Ladstetter B, Utesch D. (2001). Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures. Drug Metab Dispos 29:1042–1050.
  • Hewitt NJ, Lechón MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C, Guillouzo A, Tuschl G, Li AP, LeCluyse E, Groothuis GM, Hengstler JG. (2007). Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39:159–234.
  • Illouz S, Alexandre E, Pattenden C, Mark L, Bachellier P, Webb M, Berry D, Dennison A, Richert L. (2008). Differential effects of curcumin on cryopreserved versus fresh primary human hepatocytes. Phytother Res 22:1688–1691.
  • Jouin D, Blanchard N, Alexandre E, Delobel F, David-Pierson P, Lavé T, Jaeck D, Richert L, Coassolo P. (2006). Cryopreserved human hepatocytes in suspension are a convenient high throughput tool for the prediction of metabolic clearance. Eur J Pharm Biopharm 63:347–355.
  • Kafert-Kasting S, Alexandrova K, Barthold M, Laube B, Friedrich G, Arseniev L, Hengstler JG. (2006). Enzyme induction in cryopreserved human hepatocyte cultures. Toxicology 220:117–125.
  • Kamiguchi N, Aoyama E, Okuda T, Moriwaki T. (2010). A 96-well plate assay for CYP4503A induction using cryopreserved human hepatocytes. Drug Metab Dispos 38:1912–1916.
  • Kanebratt KP, Diczfalusy U, Bäckström T, Sparve E, Bredberg E, Böttiger Y, Andersson TB, Bertilsson L. (2008). Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol. Clin Pharmacol Ther 84:589–594.
  • Lahoz A, Donato MT, Montero S, Castell JV, Gómez-Lechón MJ. (2008a). A new in vitroapproach for the simultaneous determination of phase I and phase II enzymatic activities of human hepatocyte preparations. Rapid Commun Mass Spectrom 22:240–244.
  • Lahoz A, Donato MT, Picazo L, Castell JV, Gómez-Lechón MJ. (2008b). Assessment of cytochrome P450 induction in human hepatocytes using the cocktail strategy plus liquid chromatography tandem mass spectrometry. Drug Metab Lett 2:205–209.
  • LeCluyse EL. (2001). Human hepatocyte culture systems for the in vitroevaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci 13:343–368.
  • Lecluyse EL, Alexandre E. (2010). Isolation and culture of primary hepatocytes from resected human liver tissue. Methods Mol Biol 640:57–82.
  • LeCluyse EL, Alexandre E, Hamilton GA, Viollon-Abadie C, Coon DJ, Jolley S, Richert L. (2005). Isolation and culture of primary human hepatocytes. Methods Mol Biol 290:207–229.
  • Li AP. (2007). Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem Biol Interact 168:16–29.
  • Li AP, Gorycki PD, Hengstler JG, Kedderis GL, Koebe HG, Rahmani R, de Sousas G, Silva JM, Skett P. (1999a). Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panel. Chem Biol Interact 121:117–123.
  • Li AP, Lu C, Brent JA, Pham C, Fackett A, Ruegg CE, Silber PM. (1999b). Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chem Biol Interact 121:17–35.
  • Lloyd TD, Orr S, Skett P, Berry DP, Dennison AR. (2003). Cryopreservation of hepatocytes: a review of current methods for banking. Cell Tissue Bank 4:3–15.
  • Loretz LJ, Li AP, Flye MW, Wilson AG. (1989). Optimization of cryopreservation procedures for rat and human hepatocytes. Xenobiotica 19:489–498.
  • Lu C, Li AP. (2001). Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. Chem Biol Interact 134:271–281.
  • Lyon K, Amunom I, Neat JN, Holsapple J, Buckley D, Parkinson A. (2010). In situ evaluation of CYP1A2, CYP2B6 and CYP3A4/5 induction in cultured human hepatocytes with a cocktail of probe substrates: A comparison of percent positive control values. Drug Metab. Rev. 42:134–135.
  • Maurel P. (1996). The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Advan Drug Delivery Rev 22:105–132.
  • McGinnity DF, Soars MG, Urbanowicz RA, Riley RJ. (2004). Evaluation of fresh and cryopreserved hepatocytes as in vitrodrug metabolism tools for the prediction of metabolic clearance. Drug Metab Dispos 32:1247–1253.
  • Miners JO, Knights KM, Houston JB, Mackenzie PI. (2006). In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises. Biochem Pharmacol 71:1531–1539.
  • Nishimura M, Ejiri Y, Kishimoto S, Suzuki S, Satoh T, Horie T, Narimatsu S, Naito S. (2011). Expression levels of drug-metabolizing enzyme, transporter, and nuclear receptor mRNAs in a novel three-dimensional culture system for human hepatocytes using micro-space plates. Drug Metab Pharmacokinet 26:137–144.
  • Ostrowska A, Bode DC, Pruss J, Bilir B, Smith GD, Zeisloft S. (2000). Investigation of functional and morphological integrity of freshly isolated and cryopreserved human hepatocytes. Cell Tissue Bank 1:55–68.
  • Palmer JL, Scott RJ, Gibson A, Dickins M, Pleasance S. (2001). An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A). Br J Clin Pharmacol 52:555–561.
  • Richert L, Abadie C, Bonet A, Heyd B, Mantion G, Alexandre E, Bachellier P, Kingston S, Pattenden C, Illouz S, Dennison A, Hoffmann S, Coecke S. (2010). Inter-laboratory evaluation of the response of primary human hepatocyte cultures to model CYP inducers – a European Centre for Validation of Alternative Methods (ECVAM) – funded pre-validation study. Toxicol In Vitro 24:335–345.
  • Richert L, Alexandre E, Lloyd T, Orr S, Viollon-Abadie C, Patel R, Kingston S, Berry D, Dennison A, Heyd B, Mantion G, Jaeck D. (2004). Tissue collection, transport and isolation procedures required to optimize human hepatocyte isolation from waste liver surgical resections. A multilaboratory study. Liver Int 24:371–378.
  • Richert L, Binda D, Hamilton G, Viollon-Abadie C, Alexandre E, Bigot-Lasserre D, Bars R, Coassolo P, LeCluyse E. (2002). Evaluation of the effect of culture configuration on morphology, survival time, antioxidant status and metabolic capacities of cultured rat hepatocytes. Toxicol In Vitro 16:89–99.
  • Richert L, Liguori MJ, Abadie C, Heyd B, Mantion G, Halkic N, Waring JF. (2006). Gene expression in human hepatocytes in suspension after isolation is similar to the liver of origin, is not affected by hepatocyte cold storage and cryopreservation, but is strongly changed after hepatocyte plating. Drug Metab Dispos 34:870–879.
  • Richert L, Tuschl G, Abadie C, Blanchard N, Pekthong D, Mantion G, Weber JC, Mueller SO. (2009). Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. Toxicol Appl Pharmacol 235:86–96.
  • Roymans D, Annaert P, Van Houdt J, Weygers A, Noukens J, Sensenhauser C, Silva J, Van Looveren C, Hendrickx J, Mannens G, Meuldermans W. (2005). Expression and induction potential of cytochromes P450 in human cryopreserved hepatocytes. Drug Metab Dispos 33:1004–1016.
  • Ruegg CE, Silber PM, Mughal RA, Ismail J, Lu C, Bode DC, Li AP. (1997). Cytochrome P-450 induction and conjugated metabolism in primary human hepatocytes after cryopreservation. In Vitro Toxicol. 10:217–222.
  • Schuetz EG, Schuetz JD, Strom SC, Thompson MT, Fisher RA, Molowa DT, Li D, Guzelian PS. (1993). Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology 18:1254–1262.
  • Silva JM, Day SH, Nicoll-Griffith DA. (1999). Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes. Chem Biol Interact 121:49–63.
  • Soars MG, McGinnity DF, Grime K, Riley RJ. (2007). The pivotal role of hepatocytes in drug discovery. Chem Biol Interact 168:2–15.
  • Stéphenne X, Najimi M, Sokal EM. (2010). Hepatocyte cryopreservation: is it time to change the strategy? World J Gastroenterol 16:1–14.
  • Swales NJ, Luong C, Caldwell J. (1996). Cryopreservation of rat and mouse hepatocytes. I. Comparative viability studies. Drug Metab Dispos 24:1218–1223.
  • Swift B, Brouwer KL. (2010). Influence of seeding density and extracellular matrix on bile Acid transport and mrp4 expression in sandwich-cultured mouse hepatocytes. Mol Pharm 7:491–500.
  • Swift B, Pfeifer ND, Brouwer KL. (2010). Sandwich-cultured hepatocytes: an in vitromodel to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 42:446–471.
  • Terry C, Dhawan A, Mitry RR, Lehec SC, Hughes RD. (2010). Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation. Liver Transpl 16:229–237.
  • Turncliff RZ, Tian X, Brouwer KL. (2006). Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes. Biochem Pharmacol 71:1520–1529.
  • Zhang P, Tian X, Chandra P, Brouwer KL. (2005). Role of glycosylation in trafficking of Mrp2 in sandwich-cultured rat hepatocytes. Mol Pharmacol 67:1334–1341.
  • Zhao P, Kunze KL, Lee CA. (2005). Evaluation of time-dependent inactivation of CYP3A in cryopreserved human hepatocytes. Drug Metab Dispos 33:853–861.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.